Palisaded neutrophilic and granulomatous dermatitis presenting in a patient with rheumatoid arthritis on adalimumab

Journal of Cutaneous Pathology

Volumn 38, Issue 8, 2011, Pages 644-648

  Stephenson, Sean R ^a   Campbell, Shannon M ^a   Drew, George S ^a   Magro, Cynthia M ^b  

^a OHIO UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

adalimumab; granuloma annulare; granulomatous dermatitis; rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ANTIRHEUMATIC AGENT; AZATHIOPRINE; MONOCLONAL ANTIBODY; PREDNISONE;

ARTICLE; CASE REPORT; DERMATITIS; DRUG COMBINATION; DRUG SUBSTITUTION; FEMALE; GRANULOMA; HUMAN; MIDDLE AGED; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; RHEUMATOID ARTHRITIS; SKIN; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; DERMATITIS; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; GRANULOMA; HUMANS; MIDDLE AGED; NEUTROPHIL INFILTRATION; NEUTROPHILS; PREDNISONE; SKIN; TREATMENT OUTCOME;

EID: 79960563925     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01716.x     Document Type: Review

References (31)

1. Sayah A, English JC 3rd., Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 2005; 53: 191; quiz 210- 2.
2. Chu P, Connolly MK, LeBoit P., The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 1994; 130: 1278.
3. Magro CM, Crowson AN., The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 2003; 30: 1.
4. Bremner R, Simpson E, White CR, Morrison L, Deodhar A., Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders. Semin Arthritis Rheum 2004; 34: 610.
5. Sangueza OP, Caudell MD, Mengesha YM, et al., Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol 2002; 47: 251.
6. Goerttler E, Kutzner H, Peter HH, Requena L., Methotrexate-induced papular eruption in patients with rheumatic diseases: a distinctive adverse cutaneous reaction produced by methotrexate in patients with rheumatic diseases. J Am Acad Dermatol 1999; 40: 702.
7. Magro CM, Crowson AN, Schapiro BL., The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol 1998; 25: 72.
8. Braun MG, Van Rhee R, Becker-Capeller D., Development and/or increase of rheumatoid nodules in RA patients following leflunomide therapy. Rheumatology 2004; 63: 84.
9. Langevitz P, Maguire L, Urowitz M., Accelerated nodulosis during azathioprine therapy. Arthritis Rheum 1991; 34: 123.
10. Kekow J, Welte T, Kellner U, Pap T., Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum 2002; 46: 843.
11. Cunnane G, Warnock M, Fye KH, Daikh DI., Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 2002; 47: 445.
12. Hübscher O, Re R, Iotti R., Pulmonary rheumatoid nodules in an etanercept-treated patient. Arthritis Rheum 2003; 48: 2077.
13. Van Ede A, Den Broeder A, Wagenaar M, van Riel P, Creemers MC., Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis. J Rheumatol 2007; 34: 1590.
14. Watson P, Simler N, Screaton N, Lillicrap M., Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 928.
15. Vavricka SR, Wettstein T, Speich R, Gaspert A, Bachli EB., Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy. Thorax 2003; 58: 278.
16. Deng A, Harvey V, Sina B, et al., Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. Arch Dermatol 2006; 142: 198.
17. Metyas SK, Tadros RM, Arkfeld DG., Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis. Rheumatol Int 2009; 29: 437.
18. Voulgari PV, Markatseli TE, Exarchou SA, Zioga A, Drosos AA., Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis 2008; 67: 567.
19. Yousem SA, Dacic S., Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy. Mod Pathol 2005; 18: 651.
20. Kudrin A, Chilvers ER, Ginawi A, et al., Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol 2007; 34: 648.
21. Ishiguro T, Takayanagi N, Kurashima K, et al., Development of sarcoidosis during etanercept therapy. Intern Med 2008; 47: 1021.
22. Peno-Green L, Lluberas G, Kingsley T, Brantley S., Lung injury linked to etanercept therapy. Chest 2002; 122: 1858.
23. Hashkes PJ, Shajrawi I., Sarcoid-related uveitis occurring during etanercept therapy. Clin Exp Rheumatol 2003; 21: 645.
24. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R., Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol 2007; 26: 1969.
25. Scrivo R, Spadaro A, Iagnocco A, Valesini G., Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis. Clin Exp Rheumatol 2007; 25: 117. (Pubitemid 46477500)
26. Collaris EJ, van Marion AM, Frank J, Poblete-Gutiérrez P., Cutaneous granulomas in rheumatoid arthritis. Int J Dermatol 2007; 46 (Suppl. 3): 33.
27. Cvetković RS, Scott LJ., Adalimumab: a review of its use in adult patients with rheumatoid arthritis. BioDrugs 2006; 20: 293.
28. Ramos-Casals M, Brito-Zerõn P, Soto MJ, Cuadrado MJ, Khamashta MA., Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 2008; 22: 847.
29. Beuthien W, Mellinghoff HU, von Kempis J., Skin reaction to adalimumab. Arthritis Rheum 2004; 50: 1690.
30. Lee HH, Song IH, Friedrich M, et al., Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007; 156: 486.
31. Ueki H., Koebner phenomenon in lupus erythematosus with special consideration of clinical findings. Autoimmun Rev 2005; 4: 219.